triethylenemelamine has been researched along with Day Blindness in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-one patients treated for retinoblastoma were included in this study." | 1.32 | Visual fields in retinoblastoma survivors. ( Abramson, DH; Melson, MR; Servodidio, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, DH | 1 |
| Melson, MR | 1 |
| Servodidio, C | 1 |
1 other study available for triethylenemelamine and Day Blindness
| Article | Year |
|---|---|
Visual fields in retinoblastoma survivors.
Topics: Antineoplastic Agents, Alkylating; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; | 2004 |